Concept-to-Commercialization: Thermo Fisher's Unique Approach to Rapidly Advancing Your Antibody...

Presented By: Steve Lewis & Jeff Hou, PhD Speaker Biography: Steve Lewis currently leads a global DNA and protein biomanufacturing product portfolio at Thermo Fisher Scientific. He holds an M.S. in Biotechnology from the Johns Hopkins University, where he focused on bioprocessing and scale-up of mammalian cell lines for the development of biotherapeutics. Jeff has a Ph.D. in Biotechnology from University of Queensland, Australia, specializing in cell line development and upstream process development. He supports the Global Sales and Business Development teams in providing technical support, designing strategies and supporting new business opportunities for Thermo Fisher Scientific’s biologics manufacturing as part of the Drug Substance Division. Jeff brings a combination of academia and industry experience to developing biologics with an emphasis on early stage development and speed to clinic. Webinar: Panel Presentation: Concept-to-Commercialization: Thermo Fisher's Unique Approach to Rapidly Advancing Your Antibody and Protein Therapeutics Webinar Abstract: Rapid screening and speed of scale-up in protein therapeutics are critical factors in today’s biotech and pharma workflows. The ability to swiftly develop novel therapies often depends on cost-effective candidate screening enabled by technology innovations and process improvements that optimize and expedite the journey from original idea to commercial-scale production. Labroots on Social: Facebook:   / labrootsinc   Twitter:   / labroots   LinkedIn:   / labroots   Instagram:   / labrootsinc   Pinterest:   / labroots   SnapChat: labroots_inc